論文

査読有り 最終著者 責任著者 国際誌
2020年10月7日

Synthetic and Biophysical Studies on the Toxic Conformer in Amyloid β with the E22Δ Mutation in Alzheimer Pathology

ACS Chemical Neuroscience
  • Kazuma Murakami
  • ,
  • Tomomi Yamaguchi
  • ,
  • Naotaka Izuo
  • ,
  • Toshiaki Kume
  • ,
  • Hideyuki Hara
  • ,
  • Kazuhiro Irie

11
19
開始ページ
3017
終了ページ
3024
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1021/acschemneuro.0c00331
出版者・発行元
American Chemical Society (ACS)

The toxic conformer of the 40- or 42-mer-amyloid β-proteins (Aβ) (Aβ40, Aβ42) with a turn at positions 22 and 23 plays a role in oligomer formation, leading to neurotoxicity as part of the pathogenesis of Alzheimer's disease (AD). A deletion mutant at Glu22 (E22Δ) of Aβ, known as an Osaka mutation, accelerates oligomerization. Although E22Δ-Aβ has not been found to be toxic to cultured neuronal cells and is instead synaptotoxic in long-term potentiation, there is no information on the toxic conformer of E22Δ-Aβ in AD. The site-directed spin labeling study of E22Δ-Aβ40 by continuous wave-electron spin resonance (CW-ESR) spectroscopy in part showed the spatial proximity between positions 10 and 35, which are characteristic of the toxic conformation of Aβ, indicating the existence of a toxic conformer of Aβ with the E22Δ mutation. To obtain structural insight, E22Δ-Aβ42 substitutes with proline (F20P, A21P, D23P, and V24P), in which proline is known as a turn inducer but is a β-sheet breaker, were synthesized. An enzyme immunoassay using the 24B3 antibody recognizing toxic conformer of Aβ was carried out. 24B3 reacted with these substitutes of E22Δ-Aβ42 as well as E22Δ-Aβ42 in a similar manner to WT-Aβ42. Notably, only A21P-E22Δ-Aβ42 exhibited strong neurotoxicity in rat primary neurons after 8 days of incubation, with potent high-order oligomerization compared with E22Δ-Aβ42. These results suggest that E22Δ-Aβ42 could enhance neurotoxicity by generating a toxic oligomer conformation with a turn near position 21.

リンク情報
DOI
https://doi.org/10.1021/acschemneuro.0c00331
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32790274
共同研究・競争的資金等の研究課題
アミロイドβの毒性オリゴマーの構造解析に基づいた抗アルツハイマー病薬の開発
URL
https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00331
ID情報
  • DOI : 10.1021/acschemneuro.0c00331
  • ISSN : 1948-7193
  • eISSN : 1948-7193
  • PubMed ID : 32790274

エクスポート
BibTeX RIS